RYTHM Inc(RYM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -5.98 | Insider Own | 40.13% | Shs Outstand | 2.2M | Perf Week | -4.64% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | - | Insider Trans | -1.38% | Shs Float | 1.3M | Perf Month | -16.24% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | - | Inst Own | 7.59% | Short Float | 2.01% | Perf Quarter | -27.78% |
| Income | -0.01B | P/S | 0.5 | EPS this Y | - | Inst Trans | 2.45% | Short Ratio | 1.7 | Perf Half Y | -37.64% |
| Sales | 0.07B | P/B | 0.84 | EPS next 5Y | - | ROA | 5.56% | Short Interest | 0.03M | Perf YTD | -23.85% |
| Book/sh | 19.3 | P/C | 0.73 | EPS past 3/5Y | 88.91% 64.33% | ROE | 25.82% | 52W High | -67.75% ($50.38) | Perf Year | -61.23% |
| Cash/sh | 22.14 | P/FCF | 2.72 | Sales past 3/5Y | -33.31% 7.41% | ROIC | 16.55% | 52W Low | 16.07% ($14.00) | Perf 3Y | -33.54% |
| Dividend Est. | - | EV/EBITDA | 8 | EPS Y/Y TTM | 71.95% | Gross Margin | 58.25% | Volatility(W/M) | 7.03% 7.27% | Perf 5Y | -99.97% |
| Dividend TTM | - | EV/Sales | 0.96 | Sales Y/Y TTM | 706.93% | Oper. Margin | -7.9% | ATR (14) | 1.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.63 | EPS Q/Q | 98.7% | Profit Margin | -15.06% | RSI (14) | 40.74 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.64 | Sales Q/Q | 490.08% | SMA20 | -5.32% ($17.16) | Beta | 9.92 | Target Price | - |
| Payout | - | Debt/Eq | 1.92 | Earnings | - | SMA50 | -19.24% ($20.12) | Rel Volume | 3.26 | Prev Close | $17.61 |
| Employees | 51 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -25.91% ($21.93) | Avg Volume(3M) | 0.02M | Price | $16.25 |
| IPO | 2021/1/28 | Option/Short | No/Yes | Trades | 1541 | Volume | 50,039 | Change | -7.72% |
A Nasdaq-listed company that holds the intellectual property (IP) of popular U.S. cannabis brands and generates revenue through licensing. The company licenses THC brands such as RYTHM, Dogwalkers, and Beboe to Green Thumb Industries, operating on a brand-only model without any manufacturing facilities. In Q4 2025, revenue surged 164% quarter-over-quarter.
Over the past 1 year, on the lower side
68% below its 1-year high.
Traded more than usual. That is 326% of its average volume.
RYM has weak earnings and a weak balance sheet
Of every $100 in sales, $7.90 is lost.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $50. Peers typically go for $42.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +56% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #9 of 11 in the industry
Based on market cap of $35M.
FAQ
What kind of company is RYM?
RYM belongs to the Consumer Defensive sector and operates in the Tobacco industry.
What is the market cap of RYM?
The market cap of RYM is approximately $35M, ranking 4,978 within its sector.
What is the 52-week high and low for RYM?
RYM has recorded a 52-week high of $50.38 and a low of $14.00.
